The University of Chicago Header Logo

Olatoyosi Odenike

Concepts (455)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Olatoyosi Odenike's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Olatoyosi Odenike has written about over time.
Hematologic Neoplasms, 12 publications between 2004 and 2022, average publication date July 2011. Transplantation Conditioning, 18 publications between 2005 and 2020, average publication date August 2012. Stem Cell Transplantation, 5 publications between 2005 and 2018, average publication date November 2013. Hematopoietic Stem Cell Transplantation, 22 publications between 2006 and 2024, average publication date June 2014. Benzamides, 9 publications between 2005 and 2025, average publication date July 2014. Antineoplastic Agents, 22 publications between 2005 and 2023, average publication date March 2015. Pyrimidines, 13 publications between 2005 and 2026, average publication date July 2015. Primary Myelofibrosis, 17 publications between 2005 and 2026, average publication date September 2015. Protein Kinase Inhibitors, 12 publications between 2013 and 2026, average publication date August 2017. Blast Crisis, 5 publications between 2007 and 2024, average publication date November 2018. Leukemia, Myeloid, Acute, 44 publications between 2007 and 2026, average publication date December 2018. Mutation, 24 publications between 2006 and 2026, average publication date December 2018. Myelodysplastic Syndromes, 28 publications between 2005 and 2025, average publication date March 2019. Antineoplastic Combined Chemotherapy Protocols, 37 publications between 2004 and 2026, average publication date April 2019. Azacitidine, 14 publications between 2005 and 2025, average publication date October 2019. Myeloproliferative Disorders, 17 publications between 2011 and 2026, average publication date April 2020. Leukemia, Myelomonocytic, Chronic, 6 publications between 2017 and 2025, average publication date April 2022. Sulfonamides, 12 publications between 2014 and 2026, average publication date March 2023. Bridged Bicyclo Compounds, Heterocyclic, 9 publications between 2021 and 2026, average publication date June 2024.

To see the data from this visualization as text, click here.
Odenike's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (455)
Explore
_
Co-Authors (85)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_